диссертации / 124
.pdf91
11.Кроткова О.А. Методические рекомендации НИИ им. Н.Н. Бурденко АМН СССР / О.А. Кроткова, Т.А. Карасева, Б.А. Найдин. – М., 1986. – 30 с.
12.Кузьмина В.Ю. Влияние озонотерапии на уровень холестерина в крови при цереброваскулярной патологии / В.Ю. Кузьмина, Ю.К. Хохлов, А.А. Савин // Журнал неврологии и психиатрии им. С.С. Корсакова. – 2012. – Т. 112,
№7. – С. 58–61.
13.Левин О.С. Гетерогенность умеренного когнитивного расстройства: диагностические и терапевтические аспекты / О.С. Левин, В.Л. Голубев // Consilium medicum. – 2006. – Т. 8, № 2. – С. 106–112.
14.Лурия А.Р. Высшие корковые функции / А.Р. Лурия. – СПб.: Питер,
2008. – 624 с.
15. Лурия А.Р. Основы нейропсихологии / А.Р. Лурия. – М.: Академия,
2002. – 381 с.
16.Одинак М.М. Нарушение когнитивных функций при цереброваскулярной патологии / М.М. Одинак, А.Ю. Емелин, В.Ю. Лобзин. – СПб.: ВМедА, 2006. – 158 с.
17.Райгородский Д.Я. Практическая психодиагностика. Методики и тесты / Д.Я. Райгородский. – Самара: БАХРАМ-М, 2003. – 672 с.
18.Рубинштейн С.Я. Экспериментальные методики патопсихологии /
С.Я. Рубинштейн. – М.: ЭКСМО-Пресс, 1999. – 448 с.
19. Скворцова В.И. Эффективность хирургических и консервативных методов вторичной профилактики каротидного ишемического инсульта /
В.И. Скворцова, В.Л. Леменев, В.В. Ахметов // Журнал неврологии и психиатрии (Инсульт). – 2005. – № 13. – С. 3–7.
20. Шток В.Н. Экстрапирамидные расстройства / В.Н. Шток, И.А. Смоленская, О.С. Левин. – М.: Медпресс-информ, 2002. – С. 608.
92
21.Яхно Н.Н. Неврологическая характеристика церебральной атрофии
упациентов старших возрастных групп / Н.Н. Яхно, И.В. Дамулин // Журнал неврологии и психиатрии им. Корсакова. – 1990. – Т. 90, № 9. – С. 30–35.
22.Adachi T. Frequency and pathogenesis of silent subcortical brain infarction in acute first-ever ischemic stroke / T. Adachi, S. Kobayashi, S. Yamaguchi // Intern. Med. – 2002. – Vol. 41. – P. 103–108.
23.Akdemir I. Silent Brain Infarction in Patients with Rheumatic Mitral Steno-
sis / I. Akdemir, S. Dagdelen, M. Yuce, V. Davutoglu, M. Akcay, N. Akdemir //
J.Jpn. Heart. – 2002. – Vol. 43, № 2. – Р. 137–144.
24.Alexander G.E. Parallel organization of functionally segregated circuits linking basal ganglia and cortex / G.E. Alexander, M.E. Delong, P.L. Strick // Ann. Rwv. Neurosci. – 1986. – Vol. 9. – P. 357–381.
25.Arboix A. New concepts in lacunar stroke etiology: the constellation of small-vessel arterial disease / A. Arboix and J.L. Martí-Vilalta // Cerebrovasc. Dis. –
2004. – № 17. – Р. 58–62.
26.Arboix A. Lacunar stroke / A. Arboix and J.L. Martí-Vilalta // Expert. Rev. Neurother. – 2009. – № 9. – Р. 179–196.
27.Arboix A. Lacunar infarct and cognitive decline / A. Arboix // Expert. Rev. Neurother. – 2011. – № 11. – Р. 1251–1254.
28.Asumi M. Are serum cholesterol levels associated with silent brain infarcts? / M. Asumi, T. Yamaguchi, K. Saito // The Seiryo Clinic Study. Atherosclerosis. – 2010. – Vol. 210, № 2. – Р. 674–677.
29.Avdibegovic E. Cerebral cortical atrophy and silent brain infarcts in psychiatric patients / E. Avdibegovic, E. Becirovic, Z. Selimbasic, M. Hasanovic, O. Sinanovic // Psychiatr. Danub. – 2007. – № 19. – Р. 49–55.
93
30. Bernick C. Silent MRI infarcts and the risk of future stroke: the cardiovascular health study / C. Bernick, L. Kuller, C. Dulberg // Neurology. – 2001. – Vol. 57. – P. 1222–1229.
31.Boiten J. Lacunar infarcts: Pathogenesis and validity of the clinical syndromes / J. Boiten, J. Lodder // Stroke. – 1991. – № 22. – Р. 1374–1378.
32.Bokura H. Distinguishing silent lacunar infarc-tion from enlarged Vir- chow-Robin spaces: a magnetic resonance imaging and pathological study / H. Bokura, S. Kobayashi, S. Yamaguchi // J. Neurol . – 1998. – № 245. – Р. 116–122.
33.Boon A. Silent cerebral infarcts in 755 consecutive patients with firstever supratentorial ischemic stroke: relationship with index stroke subtype, vascular risk factors, and mortality / A. Boon, J. Lodder, L.H. Raak et al. // Stroke. –
1994. – № 25. – Р. 2384–2390.
34. Boss H.M. Vascular cognitive impairment / H.M. Boss, van den R.M. Berg-Vos, P. Scheltens, P. Weinstein // HCNed Tijdschr Geneeskd. – 2010. – № 154. – A1907.
35.Bots M.L. Prevalence of stroke in the general population: the Rotterdam Study / M.L. Bots, S.J. Looman, P.J. Koudstaal, A. Hofman, A.W. Hoes, D.E. Grobbee // Stroke. – 1996. – № 27. – Р. 1499–1501.
36.Brott T. Baseline silent cerebral infarction in the Asymptomatic Carotid Atherosclerosis Study / T. Brott, T. Tomsick, W. Feinberg // Stroke. – 1994. –
Vol. 25, № 6. – Р. 1122–1129.
37.Chandratheva A. Population-based study of risk and predictors of stroke in the first few hours after a TIA / A. Chandratheva, Z. Mehta, O.C. Geraghty, L. Marquardt, P.M. Rothwell // Neurology. – 2009. – № 72. – Р. 1941–1947.
38.Chao Feng. The 'silence' of silent brain infarctions may be related to chronic ischemic preconditioning and nonstrategic locations rather than to a small
94
infarction size / Chao Feng, Xue Bai, Yu Xu, Ting Hua, Xue-Yuan Liu // Clinics (Sao Paulo). – 2013. – Vol. 68, № 3. – Р. 365–369.
39. Chen X. Prevalence, incidence, and risk factors of lacunar infarcts in a community sample / X. Chen, W. Wen, K.J. Anstey, P.S. Sachdev // Neurology. – 2009. – Vol. 73, № 4. – Р. 266–272.
40.Chen Y. Aberrant functional networks connectivity and structural atrophy in silent lacunar infarcts: relationship with cognitive impairments / Y. Chen, J. Wang, J.J. Zhang // Alzheimers Dis. – 2014. – Vol. 42, № 3. – С. 841–850.
41.Chou C.C. Adults with late stage 3 chronic kidney disease are at high risk for prevalent silent brain infarction: a population-based study / C.C. Chou, L.M. Lien, W.H. Chen // Stroke. – 2011. – Vol. 42, № 8. – Р. 2120–2125.
42.Das R.R. Prevalence and correlates of silent cerebral infarcts in the framingham offspring study / R.R. Das, S. Seshadri, A.S. Beiser et al. // Stroke. –
2008. – № 39. – Р. 2929–2935.
43.Davis P.H. Silent cerebral infarction in patients enrolled in the TOAST Study / P.H. Davis, W.R. Clarke, B.H. Bendixen, H.P.Jr. Adams, R.F. Woolson, A. Culebras // Neurology. – 1996. – № 46. – Р. 942–948.
44.De Groot J.C. Cerebral white matter lesions and cognitive function: the Rotterdam Scan Study / De J.C. Groot, de F.E. Leeuw, M. Oudkerk et al. // Ann. Neurol. – 2000. – № 47. – Р. 145–151.
45.De Leeuw F.E. Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study / De F.E. Leeuw, de J.C. Groot // The Rotterdam Scan Study. J. Neurol. Neurosurg. Psychiatry. –
2001. – Vol. 70, № 1. – P. 9–14.
46. De Baun M.R. Silent cerebral infarcts: a review on a prevalent and progressive cause of neurologic injury in sickle cell anemia / De M.R. Baun,
95
F.D. Armstrong, R.C. McKinstry, R.E. Ware, E. Vichinsky // Blood. – 2012. – Vol. 119, № 20. – Р. 4587–4596.
47. De Baun M.R. Associated risk factors for silent cerebral infarcts in sickle cell anemia: low baseline hemoglobin, sex, and relative high systolic blood pressure / De M.R. Baun, S.A. Sarnaik, M.J. Rodeghier, C.P. Minniti // Blood. – 2012. – Vol. 119, № 16. – Р. 3684–3690.
48.De Carli C. Measures of brain morphology and infarction in the Framingham Heart Study: establishing what is normal / De C. Carli, J. Massaro, D. Harvey et al. // Neurobiol. Aging. – 2005. – № 26. – Р. 491–510.
49.Delgado P. Prevalence and associated factors of silent brain infarcts in a Mediterranean cohort of hypertensives / P. Delgado, I. Riba–Llena, J.L. Tovar, C.I. Jarca C.I. // Hypertension. – 2014. – Vol. 64, № 3. – Р. 658–663.
50.Den Heijer T. Hippocampal, amygdalar, and global brain atrophy in different apolipoprotein E genotypes / Den T. Heijer, M. Oudkerk, L.J. Launer, van C.M. Duijn, A. Hofman // Neurology. – 2002. – № 59. – Р. 746–748.
51.Desmond D.W. Vascular dementia / D.W. Desmond // Clin. Neurosci. Res. – 2004. – № 3. – Р. 437–448.
52.Dirnagl U. Pathobiology of ischaemic stroke: An integrated view / U. Dirnagl, C. Iadecola, M.A. Moskowitz // Trends Neurosci. – 1999. – № 22. – Р. 391–397.
53.Doubal F.N. Enlarged perivascular spaces on MRI are a feature of cerebral small vessel disease F.N. Doubal, A.M. MacLullich, K.J. Ferguson, M.S. Dennis, J.M. Wardlaw // Stroke. – 2010. – № 41. – Р. 450–454.
54.Dubois B. The FAB: a frontal assessement battery at bedside / B. Dubois, A. Slachevsky, I. Litvan et al. // Neurology. – 2000. – Vol. 55. – P. 1621–1626.
55.Eguchi K. Smoking is associated with silent cerebrovascular disease in a high-risk Japanese community-dwelling population / K. Eguchi, K. Kario, S. Hoshide et al. // Hypertens Res. – 2004. – № 27. – Р. 747–754.
96
56. Eguchi K. Greater impact of coexistence of hypertension and diabetes on silent cerebral infarcts / K. Eguchi, K. Kario, K. Shimada // Stroke. – 2003. – Vol. 34, № 10. – Р. 2471–2474.
57.Elbaz A. Association between the Glu298Asp polymorphism in the endothelial constitutive nitric oxide synthase gene and brain infarction. The GENIC investigators / A. Elbaz, O. Poirier, T. Moulin, F. Chedru, F. Cambien, P. Amarenco // Stroke. – 2000. – № 31. – Р. 1634–1639.
58.Erdogan D. Low serum bilirubin levels are independently and inversely related to impaired flow-mediated vasodilation and increased carotid intima-media thickness in both men and women / D. Erdogan , H. Gullu , E. Yildirim // Atherosclerosis. – 2006. – № 184. – Р. 431–437.
59.Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults / Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (adult treatment panel III) // J. Am. Med. Assoc. –
2001. – № 285. – Р. 2486–2497.
60.Fassbender K. Adhesion molecules in cerebrovascular diseases. Evidence for an inflammatory endothelial activation in cerebral largeand smallvessel disease / K. Fassbender, T. Bertsch, O. Mielke, F. Muhlhauser, M. Hennerici // Stroke. – 1999. – № 30. – Р. 1647–1650.
61.Fazekas F. MR signal abnormalities at 1,5 T in Alzheimer’s dementia
and normal aging / F. Fazekas, J. Chawluk, A. Alavi, H. Hurtig, R. Zimmerman // Am. J. Roentgenol. – 1987. – № 149. – Р. 351–356.
62. Feigin V. On behalf of the Global burden of diseases, injuries, and risk factors study 2010 (GBD 2010) and the GBD stroke experts group global and regional burden of stroke during 1990–2010: findings from the global burden of dis-
97
ease study / V. Feigin, M. Forouzanfar, R. Krishnamurthi, G. Mensah, R. Sacco //
The Lancet. – 2010. – Vol. 383, № 9913. – P. 245–255.
63.Fisher C.M. Lacunar stroke and infarcts: a review / C.M. Fisher // Neurology. – 1982. – № 32. – Р. 871–876.
64.Fisher C.M. Lacunar infarcts – a review / C.M. Fisher // Cerebrovasc Dis. – 1991. – № 1. – Р. 311–320.
65.Folstein M.F. Mini-Mental State: a practical guide for grading the mental state of patients for the clinician / M.F. Folstein, S.E. Folstein, P.R. McHugh // J. Psych. Res. – 1975. – Vol. 12. – P. 189–198.
66.Freitas S. Montreal Cognitive Assessment: validation study for mild cognitive impairment and Alzheimer disease / S. Freitas // Alzheimer Dis Assoc Disord. – 2013. – Vol. 27, № 1. – Р. 37–43.
67.Fujikawa T. Incidence of silent cerebral infarction in patients with major depression / T. Fujikawa, S. Yamawaki, Y. Touhouda // Stroke. – 1993. – № 24. –
Р. 1631–1634.
68.Fukuda K. Early menopause and the risk of silent brain infarction in community-dwelling elderly subjects: the Sefuri brain MRI study / K. Fukuda, Y. Takashima // J. Stroke Cerebrovasc Dis. – 2014. Vol. 23. – № 5. – Р. 817–822.
69.Madycki G.В. Carotid plaque texture analysis can predict the incidence of silent brain infarcts among patients undergoing carotid endarterectomy / G.B. Madycki, W.B. Staszkiewicz // European journal of vascular & endovascular surgery. – 2006. – Vol. 31. – Issue 4. – Р. 373–380.
70.Garg U.C. Nitric oxide-generating vasodilators and 8-bromocyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells / U.C. Garg, A.J. Hassid // Clin. Invest. – 1989. – № 83. – Р. 1774–1777.
98
71.Gazdzinski S. Body mass index and magnetic resonance markers of brain integrity in adults / S. Gazdzinski, J. Kornak, M.W. Weiner, D. Meyerhoff // J. Ann. Neurol. – 2008. – № 63. – Р. 652–657.
72.Giele J.L. Silent brain infarcts in patients with manifest vascular disease / J.L. Giele, T.D. Witkamp, W.P. Mali, van der Y. Graaf // Stroke. – 2004. –
Vol. 35, № 3. – Р. 742–746.
73. Giles M.F. Risk of stroke early after transient ischaemic attack: a systematic review and meta-analysis / M.F. Giles, P.M. Rothwell // Lancet Neurol. – 2007. – № 6. – Р. 1063–1072.
74.Gottesman R.F. Blood pressure and white-matter disease progression in a biethnic cohort: Atherosclerosis Risk in Communities (ARIC) study / R.F. Gottesman, J. Coresh, D.J. Catellier, A.R. Sharrett, K.M. Rose, L.H. Coker // Stroke. – 2010. – № 41. – Р. 3–8.
75.Gottesman R.F. Hemostatic factors and subclinical brain infarction in a community-based sample: the ARIC study / R.F. Gottesman, C. Cummiskey // Cerebrovasc Dis. – 2009. – Vol. 28, № 6. – Р. 589–594.
76.Grau-Olivares M. Neuropsychological abnormalities associated with lacunar infarction / M. Grau–Olivares, A. Arboix, D. Bartrés-Faz, C. Junqué // J. Neurol. Sci. – 2007. – № 257. – Р. 160–165.
77.Guliz Kozdag. Silent cerebral infarction in chronic heart failure: Ischemic and nonischemic dilated cardiomyopathy / Guliz Kozdag, Ercument Ciftci, Dilek Ural, Tayfun Sahin, Macit Selekler // Vascular Health and Risk Management. – 2008. – Vol. 4, № 2.
78.Gupta V. Silent or non-clinical infarct-like lesions in the posterior circulation territory in migraine: brain hypoperfusion or hyperperfusion? / V. Gupta // Brain. – 2006. – № 129. – E39.
99
79. Hachinski V. National Institute of Neurological Disorders and Stroke – Canadian Stroke Network vascular cognitive impairment harmonization standards / V. Hachinski, C. Iadecola, R.C. Petersen, M.M. Breteler, D.L. Nyenhuis, S.E. Black et al. // Stroke. – 2006. – № 37. – Р. 2220–2241.
80.Han I.B. Association between kinase insert domain-containing receptor gene polymorphisms and silent brain infarction: a Korean study / I.B. Han, O.J. Kim, A.E. Ropper// J. Neurol. Sci. – 2012. –Vol. 318, № 1–2. – Р. 85–89.
81.Handa K. Alcohol consumption, serum lipids and severity of angiographically determined coronary artery disease / Handa K, Sasaki J, Saku K, Kono S, Arakawa K // Am J Cardiol. 1990;65:287–289.
82.Hassan A. Markers of endothelial dysfunction in lacunar infarction and ischaemic leukoaraiosis / A. Hassan, B.J. Hunt, M. O’Sullivan et al. // Brain. –
2003. – № 126. – Р. 424–432.
83.Hatanaka R. Association of arterial stiffness with silent cerebrovascular lesions: the ohasama study / R. Hatanaka, T. Obara, D. Watabe et al. // Cerebrovasc. Dis. – 2011. – № 31. – Р. 329–337.
84.Heo S.H. High levels of serum uric acid are associated with silent brain infarction / S.H. Heo, S.H. Lee // J. Neurol. Sci. – 2010. – Vol. 297, № 1–2. – Р. 6–10.
85.Hong S.H. ACE I/D polymorphism in Korean patients with ischemic stroke and silent brain infarction / S.H. Hong, H.M. Park, J.Y. Ahn // Acta. Neurol. Scand. – 2008. – Vol. 117, № 4. – Р. 244–249.
86.Hoshi T. Relations of serum high-sensitivity C-reactive protein and inter- leukin-6 levels with silent brain infarction / T. Hoshi, K. Kitagawa, H. Yamagami, S. Furukado, H. Hougaku, M. Hori // Stroke. – 2005. – № 36. – Р. 768–772.
87.Hoshide S. Different patterns of silent cerebral infarct in patients with coronary artery disease or hypertension / S. Hoshide, K. Kario, T. Mitsuhashi et al. // Am. J. Hypertens. – 2001. – № 14. – Р. 509–515.
100
88.Hoshide S. Low-density lipoprotein Subfraction as a new risk factor for silent cerebral infarction in hypertensive patients / S. Hoshide, K. Kazuomi // Hypertension Research. – 2006. – № 29. – Р. 297–298.
89.Hougaku H. Asymptomatic carotid lesions and silent cerebral infarction / H. Hougaku, M. Matsumoto, N. Handa // Stroke. – 1994. – Vol. 25, № 3. – Р. 566–570.
90.Hougaku H. Silent cerebral infarction as a form of hypertensive target organ damage in the brain / H. Hougaku, M. Matsumoto, K. Kitagawa, K. Harada, N. Oku, T. Itoh, H. Maeda, N. Handa, T. Kamada // Hypertension. – 1992. – № 20. – Р. 816–820.
91.Hougaku H. Silent cerebral infarction in the patients with essential hypertension / H. Hougaku, M. Matsumoto, K. Kitagawa, K. Harada, N. Oku, T. Itoh, H. Maeda // Nihon. Ronen. Igakkai. Zasshi. – 1991. – Vol. 28, № 6. – Р. 741–747.
92.Hougaku H. Non-specific neurological complaints and silent cerebral infarction / H. Hougaku, M. Matumoto, T. Irino, H. Hashimoto, N. Handa, T. Kamada // Nihon. Ronen. Igakkai. Zasshi. – 1996. – Vol. 33, № 6. – Р. 460–464.
93.Howard G. Cigarette smoking and other risk factors for silent cerebral infarction in the general population / G. Howard, L.E. Wagenknecht, J. Cai, L. Cooper, M.A. Kraut, J.F. Toole // Stroke. – 1998. – № 29. – Р. 913–917.
94.Howard G. Stroke symptoms in individuals reporting no prior stroke or
transient ischemic attack are associated with a decrease in indices of mental and physical functioning / G. Howard, M.M. Safford, J.F. Meschia // Stroke. – 2007. – Vol. 38, № 9. – P. 2446–2452.
95. Igase M. Asymptomatic cerebral microbleeds seen in healthy subjects have a strong association with asymptomatic lacunar infarction / M. Igase,
Y.Tabara, K. Igase et al. // Circ. J. – 2009. – № 73. – Р. 530–533.
96.In Bo Han. Association of Methylenetetrahydrofolate Reductase (MTHFR 677C>T and 1298A>C) polymorphisms and haplotypes with silent brain